XORTX Therapeutics Inc. Increase Decrease Through Change In Equity Of Subsidiaries
XORTX Therapeutics Inc. (XRTX) reported Increase Decrease Through Change In Equity Of Subsidiaries of CAD 70.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2022-05-03.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughChangeInEquityOfSubsidiaries · last filed 2022-05-03
| Period end | Increase Decrease Through Change In Equity Of Subsidiaries 12 month |
|---|---|
| 2019-12-31 | 70.00K CAD 20-F · filed 2022-05-03 |